Functions and potential clinical applications of circular RNAs in hepatocellular carcinoma

Abstract

Hepatocellular carcinoma (HCC), which accounts for 75%-80% of primary liver cancers, is recognized worldwide as a highly lethal cancer. Adjunctive diagnostic biomarkers for HCC are α-fetoprotein (AFP), induced by the absence of vitamin K or its antagonist (PIVKA-II), and AFP-L3. Using multiple biomarkers, or biomarkers in combination with other clinical tests, is recommended from the perspective of sensitivity and specificity; however, this approach does not lend itself to early detection. Therefore, novel biomarkers are needed urgently. Non-coding RNAs, mainly circular RNAs (circRNAs), are key players in the progression and suppression of diseases, including cancer. Unlike linear RNAs, circRNAs are cyclic RNAs generated by 3’ to 5’ back-splicing. Advancements in RNA sequencing technology and bioinformatic pipelines mean that numerous circRNAs have been predicted and identified. These RNA molecules play a role in the progression/suppression of cancer through direct or indirect epigenetic regulation via microRNAs and proteins in cancer cells, as well as in the surrounding tumor microenvironment. Some circRNAs are tissue- or cell line-specific and are detected in exosomes, blood, and saliva. Importantly, circRNAs are more stable than linear cognate RNAs in vivo. This unique characteristic positions circRNAs as versatile materials with potential for use as biomarkers, in clinical tests, and as therapeutic applications. In the context of HCC, numerous circRNAs have been identified. Here, we describe the functions of circRNAs in HCC, the experimental methods in which they can be used, and their potential clinical applications.

Keywords

Non-coding RNA / circular RNA / biomarker / experiment

References

[1] Sung H,Siegel RL.Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[2] Yang JD,Gores GJ,Plymoth A.A global view of hepatocellular carcinoma: trends, risk, prevention and management.Nat Rev Gastroenterol Hepatol2019;16:589-604 PMCID:PMC6813818

[3] Omata M,Kokudo N.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Hepatol Int2017;11:317-70 PMCID:PMC5491694

[4] Tian Y,Liu LX.Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.Front Immunol2024;15:1400744 PMCID:PMC11116607

[5] Project Consortium. An integrated encyclopedia of DNA elements in the human genome.Nature2012;489:57-74 PMCID:PMC3439153

[6] Mercer TR,Mattick JS.Long non-coding RNAs: insights into functions.Nat Rev Genet2009;10:155-9

[7] Glažar P,Rajewsky N.circBase: a database for circular RNAs.RNA2014;20:1666-70 PMCID:PMC4201819

[8] Sanger HL,Riesner D,Kleinschmidt AK.Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures.Proc Natl Acad Sci U S A1976;73:3852-6 PMCID:PMC431239

[9] Capel B,Nicolis S.Circular transcripts of the testis-determining gene Sry in adult mouse testis.Cell1993;73:1019-30

[10] Chen CK,Demeter J.Structured elements drive extensive circular RNA translation.Mol Cell2021;81:4300-18.e13 PMCID:PMC8567535

[11] Zhang Y,Li X.The biogenesis of nascent circular RNAs.Cell Rep2016;15:611-24

[12] Fan X,Wu X.Single-cell RNA-seq transcriptome analysis of linear and circular RNAs in mouse preimplantation embryos.Genome Biol2015;16:148 PMCID:PMC4511241

[13] Memczak S,Elefsinioti A.Circular RNAs are a large class of animal RNAs with regulatory potency.Nature2013;495:333-8

[14] Hsu MT.Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells.Nature1979;280:339-40

[15] Nigro JM,Fearon ER.Scrambled exons.Cell1991;64:607-13

[16] Salzman J,Wang PL,Brown PO.Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types.PLoS One2012;7:e30733 PMCID:PMC3270023

[17] Enuka Y,Feldman ME,Ulitsky I.Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor.Nucleic Acids Res2016;44:1370-83 PMCID:PMC4756822

[18] Huang K, Li N, Li Y, et al. Delivery of circular mRNA via degradable lipid nanoparticles against SARS-CoV-2 delta variant. bioRxiv 2022;bioRxiv:2022.05.12.491597.

[19] Qu L,Shen Y.Circular RNA vaccines against SARS-CoV-2 and emerging variants.Cell2022;185:1728-44.e16 PMCID:PMC8971115

[20] Li H,Lai W.Comprehensive circular RNA profiles in plasma reveals that circular RNAs can be used as novel biomarkers for systemic lupus erythematosus.Clin Chim Acta2018;480:17-25

[21] Memczak S,Peters O.Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood.PLoS One2015;10:e0141214 PMCID:PMC4617279

[22] Vo JN,Zhang Y.The landscape of circular RNA in cancer.Cell2019;176:869-81.e13 PMCID:PMC6601354

[23] Bahn JH,Li F.The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva.Clin Chem2015;61:221-30 PMCID:PMC4332885

[24] Maass PG,Memczak S.A map of human circular RNAs in clinically relevant tissues.J Mol Med2017;95:1179-89 PMCID:PMC5660143

[25] Preußer C,Schneider T.Selective release of circRNAs in platelet-derived extracellular vesicles.J Extracell Vesicles2018;7:1424473 PMCID:PMC5769804

[26] Zhao X,Xu J.Circular RNAs: biogenesis, mechanism, and function in human cancers.Int J Mol Sci2019;20:3926 PMCID:PMC6720291

[27] Lee Y.Mechanisms and regulation of alternative pre-mRNA splicing.Annu Rev Biochem2015;84:291-323 PMCID:PMC4526142

[28] Jeck WR,Wang K.Circular RNAs are abundant, conserved, and associated with ALU repeats.RNA2013;19:141-57 PMCID:PMC3543092

[29] Ivanov A,Wyler E.Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals.Cell Rep2015;10:170-7

[30] Conn SJ,Toubia J.The RNA binding protein quaking regulates formation of circRNAs.Cell2015;160:1125-34

[31] Fei T,Xiao T.Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.Proc Natl Acad Sci U S A2017;114:E5207-15 PMCID:PMC5495225

[32] Errichelli L,Laneve P.FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons.Nat Commun2017;8:14741 PMCID:PMC5379105

[33] Ashwal-Fluss R,Pamudurti NR.circRNA biogenesis competes with pre-mRNA splicing.Mol Cell2014;56:55-66

[34] Shi L,Liang Y.Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma.Cell Death Dis2017;8:e3171 PMCID:PMC5775411

[35] Chen Q,Li Z.Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription.J Hepatol2022;76:135-47

[36] Zhang Y,Chen T.Circular intronic long noncoding RNAs.Mol Cell2013;51:792-806

[37] Li Z,Bao C.Exon-intron circular RNAs regulate transcription in the nucleus.Nat Struct Mol Biol2015;22:256-64

[38] Broderick JA.Competitive endogenous RNAs cannot alter microRNA function in vivo.Mol Cell2014;54:711-3

[39] Fei D,Wang Y.Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway.Mol Cancer2024;23:159 PMCID:PMC11302160

[40] Tian Y,Lv K,Zhou X.CircSNX6 promotes proliferation, metastasis, and angiogenesis in hepatocellular carcinoma via miR-383-5p/VEGFA signaling pathway.Sci Rep2024;14:8243 PMCID:PMC11001896

[41] Liang WC,Liang PP.Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway.Genome Biol2019;20:84 PMCID:PMC6486691

[42] Li H,Jiang Y.Circular RNA circDCUN1D4 suppresses hepatocellular carcinoma development via targeting the miR-590-5p/ TIMP3 axis.Mol Cancer2025;24:95 PMCID:PMC11934760

[43] Xu J,Liang Y.CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1.Signal Transduct Target Ther2020;5:298 PMCID:PMC7762756

[44] Huang XY,Zhang PB.CircRNA-100338 is associated with mTOR signaling pathway and poor prognosis in hepatocellular carcinoma.Front Oncol2019;9:392 PMCID:PMC6528706

[45] Huang XY,Huang J.Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis.J Exp Clin Cancer Res2020;39:20 PMCID:PMC6979009

[46] Yu J,Wang ZG.Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.J Hepatol2018;68:1214-27

[47] Wang L,Zheng Q,Xiao X.Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.Mol Cancer2019;18:119 PMCID:PMC6639939

[48] Huang XY,Wei CY.Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.Mol Cancer2020;19:92 PMCID:PMC7236145

[49] Zhao J,Wu P.circRNA-0015004 act as a ceRNA to promote RCC2 expression in hepatocellular carcinoma.Sci Rep2024;14:16913 PMCID:PMC11266727

[50] Chen G,Liu M.circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma.Cell Death Dis2018;9:175 PMCID:PMC5833724

[51] Wei Y,Liang C.A noncoding regulatory RNAs network driven by circ-CDYL acts specifically in the early stages hepatocellular carcinoma.Hepatology2020;71:130-47

[52] Hu ZQ,Li J.Circular RNA sequencing identifies circASAP1 as a key regulator in hepatocellular carcinoma metastasis.Hepatology2020;72:906-22

[53] Sun C,Liu M.A novel circular RNA, circ_0005394, predicts unfavorable prognosis and contributes to hepatocellular carcinoma progression by regulating miR-507/E2F3 and miR-515-5p/CXCL6 signaling pathways.Onco Targets Ther2020;13:6171-80 PMCID:PMC7334013

[54] Zhu YJ,Luo GJ.Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma.Theranostics2019;9:3526-40 PMCID:PMC6587157

[55] Zhang PF,Huang XY.Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.Mol Cancer2019;18:105 PMCID:PMC6545035

[56] Han D,Wang H.Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.Hepatology2017;66:1151-64

[57] Wang J,Wang W.Mechanism of the regulatory effect of overexpression of circMTO1 on proliferation and apoptosis of hepatoma cells via miR-9-5p/NOX4 axis.Cancer Manag Res2020;12:3915-25 PMCID:PMC7263879

[58] Li D,Yang J.CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.Cell Death Dis2021;13:12 PMCID:PMC8688446

[59] Zhong L,Cheng Y.Circular RNA circC3P1 suppresses hepatocellular carcinoma growth and metastasis through miR-4641/PCK1 pathway.Biochem Biophys Res Commun2018;499:1044-9

[60] Qiu L,Li Z.Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.Mol Oncol2019;13:441-55 PMCID:PMC6360375

[61] Li Y,Zhao J.HNRNPL circularizes ARHGAP35 to produce an oncogenic protein.Adv Sci (Weinh)2021;8:2001701 PMCID:PMC8261482

[62] Song R,Xu J.A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR.Mol Cancer2023;22:16 PMCID:PMC9869513

[63] Chen S,Zhang J,Zhang B.circVAMP3 drives CAPRIN1 phase separation and inhibits hepatocellular carcinoma by suppressing c-Myc translation.Adv Sci (Weinh)2022;9:e2103817 PMCID:PMC8922094

[64] Rossi F,Megiorni F.Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma.Oncogene2019;38:3843-54 PMCID:PMC6544520

[65] Rossi F,Damizia M.Circular RNA ZNF609/CKAP5 mRNA interaction regulates microtubule dynamics and tumorigenicity.Mol Cell2022;82:75-89.e9 PMCID:PMC8751636

[66] Hanahan D.The hallmarks of cancer.Cell2000;100:57-70

[67] He Y,Jin L.CircZNF609 enhances hepatocellular carcinoma cell proliferation, metastasis, and stemness by activating the Hedgehog pathway through the regulation of miR-15a-5p/15b-5p and GLI2 expressions.Cell Death Dis2020;11:358 PMCID:PMC7217914

[68] Yao H,Lin MC.Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma.Cancer Lett2016;379:213-9

[69] Lu JC,Huang XY.Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.J Hematol Oncol2021;14:200 PMCID:PMC8627086

[70] Rao G,Tian Y,Zhang Y.Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology.Front Genet2023;14:1106665 PMCID:PMC10361733

[71] Zhang N.CD8⁺ T cells: foot soldiers of the immune system.Immunity2011;35:161-8 PMCID:PMC3303224

[72] Hu Z,Zhao Y.Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.Mol Cancer2023;22:55 PMCID:PMC10024440

[73] Zhang PF,Huang XY.Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.Mol Cancer2020;19:110 PMCID:PMC7320583

[74] Nishikawa H.Regulatory T cells in cancer immunotherapy.Curr Opin Immunol2014;27:1-7

[75] Huang M,Huang N.Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells.Cancer Sci2022;113:1968-83 PMCID:PMC9207376

[76] Ying F,Lee TKW.Cancer-associated fibroblasts in hepatocellular carcinoma and cholangiocarcinoma.Cell Mol Gastroenterol Hepatol2023;15:985-99 PMCID:PMC10040968

[77] Liu G,Yang ZF.Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis.Cell Death Dis2021;12:260 PMCID:PMC7952559

[78] Ma YY,Wang HJ.Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer.Cancer Sci2011;102:336-42

[79] Lan J,Xu F.M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer.Cancer Res2019;79:146-58

[80] Hao X,Zhang Y.Targeting immune cells in the tumor microenvironment of HCC: new opportunities and challenges.Front Cell Dev Biol2021;9:775462 PMCID:PMC8633569

[81] Wang Y,Li J.Downregulation of hsa_circ_0074854 suppresses the migration and invasion in hepatocellular carcinoma via interacting with HuR and via suppressing exosomes-mediated macrophage M2 polarization.Int J Nanomedicine2021;16:2803-18 PMCID:PMC8052130

[82] Kudo M,Qin S.Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.Lancet2018;391:1163-73

[83] Finn RS,Ikeda M.Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.N Engl J Med2020;382:1894-905

[84] Tang W,Zhang W.The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects.Signal Transduct Target Ther2020;5:87 PMCID:PMC7292831

[85] Chang Z,Luo F,Cai Y.Circular RNA SMARCA5 promotes a poor prognosis and radiotherapy resistance for patients with hepatocellular carcinoma.Ann Clin Lab Sci2023;53:573-77

[86] Duan J,Huang Y.SNAI2-induced circMTO1 promotes cell proliferation and inhibits apoptosis through the miR-320b/MCL1 axis in human granulosa-like tumor cells.Front Genet2021;12:689916 PMCID:PMC8369758

[87] Zhang X,Zhang W,Wang Y.Circular RNA circMTO1 inhibits proliferation of glioblastoma cells via miR-92/WWOX signaling pathway.Med Sci Monit2019;25:6454-61 PMCID:PMC6738003

[88] Liu DY,Zhang K.Circular RNA CircMTO1 suppressed proliferation and metastasis of osteosarcoma through miR-630/KLF6 axis.Eur Rev Med Pharmacol Sci2021;25:86-93

[89] Wang P,Li D,Wei L.circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-β/Smad and EGFR pathways.Oncol Lett2021;22:563 PMCID:PMC8185704

[90] Chen M,Zhou J,Li H.circMTO1 promotes tumorigenesis and chemoresistance of cervical cancer via regulating miR-6893.Biomed Pharmacother2019;117:109064

[91] Yu N,Chen W.CircRNA ZKSCAN1 promotes lung adenocarcinoma progression by miR-185-5p/TAGLN2 axis.Thorac Cancer2023;14:1467-76 PMCID:PMC10234786

[92] Hutvágner G.A microRNA in a multiple-turnover RNAi enzyme complex.Science2002;297:2056-60

[93] Imanishi S,Fujita T.Circular RNAs hsa_circ_0001438 and hsa_circ_0000417 are downregulated and upregulated, respectively, in hepatocellular carcinoma.Int J Exp Pathol2022;103:245-51 PMCID:PMC9664408

[94] Wang Z,Zheng Y.Involvement of circRNAs in proinflammatory cytokines-mediated β-Cell dysfunction.Mediators Inflamm2021;2021:5566453 PMCID:PMC8112919

[95] Yuan X,Ou S.Diagnostic accuracy of circulating exosomal circRNAs in malignances: a meta-analysis and systematic review.Medicine (Baltimore)2023;102:e33872 PMCID:PMC10219741

[96] Wang M,Xu J,Ren X.CircRNAs as biomarkers of cancer: a meta-analysis.BMC Cancer2018;18:303 PMCID:PMC5859638

[97] Nie G,Li B.Diagnostic accuracy of serum/plasma circular RNAs and the combination of circular RNAs and α-fetoprotein for detecting hepatocellular carcinoma: a meta-analysis.Front Genet2021;12:722208 PMCID:PMC8514948

[98] Bedair HM,Ahmed EA.Evaluation of circular RNA SMARCA5 as a novel biomarker for hepatocellular carcinoma.Asian Pac J Cancer Prev2024;25:1411-7 PMCID:PMC11162735

[99] Ji Y,Yan X.CircCRIM1 promotes hepatocellular carcinoma proliferation and angiogenesis by sponging miR-378a-3p and regulating SKP2 expression.Front Cell Dev Biol2021;9:796686 PMCID:PMC8634842

[100] Feng Y,Jia W.Circ_0007386 promotes the progression of hepatocellular carcinoma through the miR-507/ CCNT2 axis.J Hepatocell Carcinoma2024;11:1095-112 PMCID:PMC11182359

[101] Li ZD,Lu J,Zhang C.Recent research progress of circular RNAs in hepatocellular carcinoma.Front Oncol2024;13:1192386 PMCID:PMC10844539

[102] Tang Y,Cao M.CircRNA-mTOR promotes hepatocellular carcinoma progression and lenvatinib resistance through the PSIP1/c-Myc axis.Adv Sci (Weinh)2025;12:e2410591 PMCID:PMC12120768

[103] Orna Therapeutics. Merck and orna therapeutics collaborate to advance Orna’s next generation of RNA technology. Available from: https://www.ornatx.com/merck-and-orna-therapeutics-collaborate-to-advance-ornas-next-generation-of-rna-technology%ef%bf%bc/. [Last accessed on 17 Jun 2025].

[104] Jost I,Gerresheim GK,Bindereif A.Functional sequestration of microRNA-122 from hepatitis C Virus by circular RNA sponges.RNA Biol2018;15:1032-9 PMCID:PMC6161685

[105] Niu D,Lian J.Circular RNA vaccine in disease prevention and treatment.Signal Transduct Target Ther2023;8:341 PMCID:PMC10493228

[106] Xie J,Deng X.Circular RNA: a promising new star of vaccine.J Transl Int Med2023;11:372-81 PMCID:PMC10732498

[107] Bu T,Zhao J,Li F.Expanding the potential of circular RNA (CircRNA) vaccines: a promising therapeutic approach.Int J Mol Sci2025;26:379 PMCID:PMC11722184

[108] Shen H,Xu J.Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer.J Hematol Oncol2021;14:134 PMCID:PMC8407006

[109] Wang F,Wang Y.Circular RNA-based neoantigen vaccine for hepatocellular carcinoma immunotherapy.MedComm2024;5:e667 PMCID:PMC11286538

[110] Li H,Yang K.Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies.Theranostics2022;12:6422-36 PMCID:PMC9475446

[111] Liu CX,Nan F,Yang L.RNA circles with minimized immunogenicity as potent PKR inhibitors.Mol Cell2022;82:420-34.e6

[112] Zhang J,Zheng Y,Qiu Z.CircRNA as an Achilles heel of cancer: characterization, biomarker and therapeutic modalities.J Transl Med2024;22:752 PMCID:PMC11316389

[113] Sun D.Structure and function of cationic and ionizable lipids for nucleic acid delivery.Pharm Res2023;40:27-46 PMCID:PMC9812548

[114] Fan N,Zhu R.Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants.Sci Adv2022;8:eabq3500 PMCID:PMC9788765

[115] Chen R,Belk JA.Engineering circular RNA for enhanced protein production.Nat Biotechnol2023;41:262-72 PMCID:PMC9931579

[116] Zhang L,Chen C.Circular siRNAs for reducing off-target effects and enhancing long-term gene silencing in cells and mice.Mol Ther Nucleic Acids2018;10:237-44 PMCID:PMC5768153

[117] Yang J,Sun J.Intratumoral delivered novel circular mRNA encoding cytokines for immune modulation and cancer therapy.Mol Ther Nucleic Acids2022;30:184-97 PMCID:PMC9482165

[118] Amiri A,Ansari Dezfouli E,Jafari R.Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications.J Transl Med2022;20:125 PMCID:PMC8919142

[119] Suzuki H,Wang J,Malhotra A.Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing.Nucleic Acids Res2006;34:e63 PMCID:PMC1458517

[120] Hansen TB.Improved circRNA identification by combining prediction algorithms.Front Cell Dev Biol2018;6:20 PMCID:PMC5844931

[121] Zeng X,Guo M.A comprehensive overview and evaluation of circular RNA detection tools.PLoS Comput Biol2017;13:e1005420 PMCID:PMC5466358

[122] Jeck WR.Detecting and characterizing circular RNAs.Nat Biotechnol2014;32:453-61 PMCID:PMC4121655

[123] Yao Z,Hu K.ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways.Mol Oncol2017;11:422-37 PMCID:PMC5527481

[124] Nielsen AF,Bozzoni I.Best practice standards for circular RNA research.Nat Methods2022;19:1208-20 PMCID:PMC9759028

[125] Zhang XO,Zhang Y.Diverse alternative back-splicing and alternative splicing landscape of circular RNAs.Genome Res2016;26:1277-87 PMCID:PMC5052039

[126] Szabo L.Detecting circular RNAs: bioinformatic and experimental challenges.Nat Rev Genet2016;17:679-92 PMCID:PMC5565156

[127] Liu CX.Circular RNAs: characterization, cellular roles, and applications.Cell2022;185:2016-34

[128] Hetzer MW.The nuclear envelope.Cold Spring Harb Perspect Biol2010;2:a000539 PMCID:PMC2829960

[129] Chujo T,Kawaguchi T.Unusual semi-extractability as a hallmark of nuclear body-associated architectural noncoding RNAs.EMBO J2017;36:1447-62 PMCID:PMC5430218

[130] Wu M,Han C.lncRNA SLERT controls phase separation of FC/DFCs to facilitate Pol I transcription.Science2021;373:547-55

[131] You X,Babic A.Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity.Nat Neurosci2015;18:603-10 PMCID:PMC4376664

[132] Hansen TB,Clausen BH.Natural RNA circles function as efficient microRNA sponges.Nature2013;495:384-8

[133] Li X,Xue W.Coordinated circRNA biogenesis and function with NF90/NF110 in viral infection.Mol Cell2017;67:214-27.e7

[134] Liang D.Short intronic repeat sequences facilitate circular RNA production.Genes Dev2014;28:2233-47 PMCID:PMC4201285

[135] Starke S,Rossbach O.Exon circularization requires canonical splice signals.Cell Rep2015;10:103-11

[136] Guarnerio J,Cheloni G.Intragenic antagonistic roles of protein and circRNA in tumorigenesis.Cell Res2019;29:628-40 PMCID:PMC6796857

[137] Litke JL.Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts.Nat Biotechnol2019;37:667-75 PMCID:PMC6554452

[138] Chen S,Xu X.Widespread and functional RNA circularization in localized prostate cancer.Cell2019;176:831-43.e22

[139] Pamudurti NR,Krishnamoorthy A,Bartok O.An in vivo strategy for knockdown of circular RNAs.Cell Discov2020;6:52 PMCID:PMC7417560

[140] Guarnerio J,Jeong JC.Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations.Cell2016;165:289-302

[141] Li S,Xue W.Screening for functional circular RNAs using the CRISPR-Cas13 system.Nat Methods2021;18:51-9

[142] Piwecka M,Hernandez-Miranda LR.Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function.Science2017;357:eaam8526

[143] Gao X,Li X.Knockout of circRNAs by base editing back-splice sites of circularized exons.Genome Biol2022;23:16 PMCID:PMC8744252

[144] Li X,Chen LL.The biogenesis, functions, and challenges of circular RNAs.Mol Cell2018;71:428-42

[145] Hama Faraj GS,Abdullah SR.Advanced approaches of the use of circRNAs as a replacement for cancer therapy.Noncoding RNA Res2024;9:811-30 PMCID:PMC10999493

[146] Aldén M,Yang D.Intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 in vitro in human liver cell line.Curr Issues Mol Biol2022;44:1115-26 PMCID:PMC8946961

[147] Long J,Zhang H.Novel ionizable lipid nanoparticles for SARS-CoV-2 omicron mRNA delivery.Adv Healthc Mater2023;12:e2202590

[148] Alqahtani S,Venkatesan K.Unveiling pharmacogenomics insights into circular RNAs: toward precision medicine in cancer therapy.Biomolecules2025;15:535 PMCID:PMC12024797

[149] Long G,Shi R,Hu Z.Circular RNAs and drug resistance in genitourinary cancers: a literature review.Cancers (Basel)2022;14:866 PMCID:PMC8869870

[150] Piergentili R,Nocella C.Using ncRNAs as tools in cancer diagnosis and treatment-the way towards personalized medicine to improve patients’ health.Int J Mol Sci2022;23:9353 PMCID:PMC9409241